TELO — Telo Genomics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$9.00m
- CA$6.75m
Annual cashflow statement for Telo Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.24 | -1.07 | -2.11 | -2.82 | -2.71 |
| Depreciation | |||||
| Non-Cash Items | 0.264 | -0.046 | 0.151 | 0.16 | 0.056 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.206 | -0.051 | 0.107 | -0.002 | 0.158 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.12 | -1.1 | -1.79 | -2.63 | -2.46 |
| Capital Expenditures | — | -0.009 | -0.025 | -0.069 | -0.005 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.009 | 0 | — | — | — |
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.009 | -0.009 | -0.025 | -0.069 | -0.005 |
| Financing Cash Flow Items | -0.106 | -0.149 | -0.017 | -0.207 | -0.04 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.03 | 3.83 | 0.877 | 2.68 | 0.587 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.901 | 2.72 | -0.944 | -0.02 | -1.88 |